Solid Tumors with Fgfr2 Alterations
📧 Sign up to get email alerts when something new happens for Solid Tumors with Fgfr2 Alterations.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 3HP-2827 in adults with solid tumors harboring FGFR2 alterations; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations [Phase 1]
This is a first-in-human Phase 1 trial of 3HP-2827 in adults with unresectable or metastatic solid tumors bearing FGFR2 alterations, and the…